A cancer trial scandal and its regulatory backlash. Nat Biotechnol 2014 Jan;32(1):27-31
Date
01/11/2014Pubmed ID
24406925DOI
10.1038/nbt.2792Scopus ID
2-s2.0-84892181395 (requires institutional sign-in at Scopus site) 12 CitationsAuthor List
Kurzrock R, Kantarjian H, Stewart DJAuthor
Razelle Kurzrock MD Center Associate Director, Professor in the Medicine department at Medical College of WisconsinMESH terms used to index this publication - Major topics in bold
Clinical Trials as TopicHumans
Neoplasms
United States
United States Food and Drug Administration
